Knight Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Knight Therapeutics's estimated annual revenue is currently $187.3M per year.
- Knight Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Knight Therapeutics has 932 Employees.
- Knight Therapeutics grew their employee count by 6% last year.
Knight Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Business Officer | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Director, Global Sales Operations | Reveal Email/Phone |
4 | Territory Business Manager | Reveal Email/Phone |
5 | Associate Director Business Development | Reveal Email/Phone |
6 | Executive Chair | Reveal Email/Phone |
7 | Regulatory Affairs Operations Associate | Reveal Email/Phone |
8 | Territory Business Manager-Onc | Reveal Email/Phone |
Knight Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.2M | 16 | 7% | N/A | N/A |
#2 | $30.2M | 150 | 1% | N/A | N/A |
#3 | $10.7M | 100 | 5% | $39.7M | N/A |
#4 | $104.3M | 519 | 22% | N/A | N/A |
#5 | $47.8M | 238 | N/A | N/A | N/A |
#6 | $15.5M | 77 | 5% | N/A | N/A |
#7 | $395.8M | 1969 | 7% | N/A | N/A |
#8 | $187.3M | 932 | 6% | N/A | N/A |
#9 | $361.6M | 1799 | 6% | N/A | N/A |
#10 | $27.5M | 137 | 0% | N/A | N/A |
What Is Knight Therapeutics?
Knight Therapeutics Inc. (TSX: GUD) is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products in Canada and select international markets. In addition, Knight conducts late-stage clinical development on low risk, low expense product opportunities. All of Knight’s products are sourced through partnerships.\r\n\r\nUnlike many other specialty pharmaceutical companies, Knight has the flexibility to explore opportunities in a range of therapeutic areas.
keywords:N/A
N/A
Total Funding
932
Number of Employees
$187.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Knight Therapeutics News
Knight Therapeutics Inc. (OTCMKTS:KHTRF) Given Average Rating ... Defense World
Knight Therapeutics Inc. (TSE:GUD) Receives Consensus ... Defense World
Knight Therapeutics Inc. (TSE:GUD) Director Robert Nathaniel ... Defense World